Skip to Main Content

Paper Details

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
J Clin Invest
49
2021
Author NameAffiliation
Leslie CopeJohns Hopkins University
Yuexin LiuWinship Cancer Institute of Emory University
Yuexin LiuWinship Cancer Institute of Emory University
  • 1 - 3

Datasets

Release 1.2